Future prospects for new vaccines against STIs

Current Opinion in Infectious Diseases, February 2017 – Volume 30 – Issue 1 – p 77–86
This review provides an update on the need, development status, and important next steps for advancing development of vaccines against sexually transmitted infections (STIs), including herpes simplex virus (HSV), Neisseria gonorrhoeae (gonorrhea), Chlamydia trachomatis (chlamydia), and Treponema pallidum (syphilis).

Major progress is being made in addressing the large global unmet need for STI vaccines. With continued collaboration and support, these critically important vaccines for global sexual and reproductive health can become a reality.

  • Full text (open access) available here

Are antimicrobial condoms the new frontier against STIs? Not quite…

The Conversation, 13 October 2014, 6.09am AEDT

Australian biotech company Starpharma has announced the imminent launch of a condom coated with an antimicrobial chemical.

While it might be marketed as a great leap forward for preventing sexually transmitted infections (STIs), it’s unlikely to offer any more protection than your average condom.

Read more here